Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Feb;117(3):488–492. doi: 10.1111/j.1476-5381.1996.tb15216.x

Antagonism by SR 48692 of mechanical responses to neurotensin in rat intestine.

F Mulè 1, R Serio 1, A Postorino 1, T Vetri 1, F Bonvissuto 1
PMCID: PMC1909323  PMID: 8821538

Abstract

1. The effects of SR 48692 on neurotensin (NT)-induced mechanical responses were investigated in rat duodenum and proximal colon by use of isometric, isovolumic preparations. 2. SR 48692 inhibited the relaxant responses to NT in duodenal circular and longitudinal muscle. It also antagonized the NT-induced contractile effects in duodenal circular muscle and in proximal colon (both muscular layers). 3. From Schild analysis and pA2 value for SR 48692 was 8.2 in tissues where NT induced relaxant effects and 7.5 in tissues where NT induced contractile effects and the slope of the regression line was not significantly different from unity, indicating competitive antagonism. 4. SR 48692 did not antagonize the duodenal relaxant effect induced by noradrenaline and the contractile response to carbachol or substance P in duodenum and colon. 5. Our results demonstrate that SR 48692 selectively antagonizes the mechanical actions of NT in rat intestine and confirm the existence of specific NT receptors. Receptors that subserve a relaxant effect seem to be related, but not identical, to those that mediate contractile effects.

Full text

PDF
488

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Al-Saffar A., Rosell S. Effects of neurotensin and neurotensin analogues on the migrating myoelectrical complexes in the small intestine of rats. Acta Physiol Scand. 1981 Jun;112(2):203–208. doi: 10.1111/j.1748-1716.1981.tb06805.x. [DOI] [PubMed] [Google Scholar]
  3. Behbehani M. M. Physiological mechanisms of the analgesic effect of neurotensin. Ann N Y Acad Sci. 1992;668:253–265. doi: 10.1111/j.1749-6632.1992.tb27354.x. [DOI] [PubMed] [Google Scholar]
  4. Bissette G., Nemeroff C. B., Loosen P. T., Prange A. J., Jr, Lipton M. A. Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature. 1976 Aug 12;262(5569):607–609. doi: 10.1038/262607a0. [DOI] [PubMed] [Google Scholar]
  5. Buchan A. M., Barber D. L. Neurotensin-containing neurons in the canine enteric innervation. Neurosci Lett. 1987 Apr 23;76(1):13–17. doi: 10.1016/0304-3940(87)90184-4. [DOI] [PubMed] [Google Scholar]
  6. Cochrane D. E. Peptide regulation of mast-cell function. Prog Med Chem. 1990;27:143–188. doi: 10.1016/s0079-6468(08)70291-1. [DOI] [PubMed] [Google Scholar]
  7. Dubuc I., Costentin J., Terranova J. P., Barnouin M. C., Soubrié P., Le Fur G., Rostène W., Kitabgi P. The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes. Br J Pharmacol. 1994 Jun;112(2):352–354. doi: 10.1111/j.1476-5381.1994.tb13077.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goedert M., Hunter J. C., Ninkovic M. Evidence for neurotensin as a non-adrenergic, non-cholinergic neurotransmitter in guinea pig ileum. Nature. 1984 Sep 6;311(5981):59–62. doi: 10.1038/311059a0. [DOI] [PubMed] [Google Scholar]
  9. Gully D., Canton M., Boigegrain R., Jeanjean F., Molimard J. C., Poncelet M., Gueudet C., Heaulme M., Leyris R., Brouard A. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):65–69. doi: 10.1073/pnas.90.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hall J. M., Caulfield M. P., Watson S. P., Guard S. Receptor subtypes or species homologues: relevance to drug discovery. Trends Pharmacol Sci. 1993 Oct;14(10):376–383. doi: 10.1016/0165-6147(93)90096-3. [DOI] [PubMed] [Google Scholar]
  11. Kasckow J., Nemeroff C. B. The neurobiology of neurotensin: focus on neurotensin-dopamine interactions. Regul Pept. 1991 Oct 29;36(2):153–164. doi: 10.1016/0167-0115(91)90053-j. [DOI] [PubMed] [Google Scholar]
  12. Kitabgi P., Checler F., Mazella J., Vincent J. P. Pharmacology and biochemistry of neurotensin receptors. Rev Clin Basic Pharm. 1985 Jul-Dec;5(3-4):397–486. [PubMed] [Google Scholar]
  13. Komori S., Fukutome T., Ohashi H. Isolation of a peptide material showing strong rectal muscle-contracting activity from chicken rectum and its identification as chicken neurotensin. Jpn J Pharmacol. 1986 Apr;40(4):577–589. doi: 10.1254/jjp.40.577. [DOI] [PubMed] [Google Scholar]
  14. Komori S., Matsuoka T., Kwon S. C., Takewaki T., Ohashi H. Membrane potential and current responses to neurotensin in the longitudinal muscle of the rectum of the fowl. Br J Pharmacol. 1992 Nov;107(3):790–796. doi: 10.1111/j.1476-5381.1992.tb14525.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Labbé-Jullié C., Deschaintres S., Gully D., Le Fur G., Kitabgi P. Effect of the nonpeptide neurotensin antagonist, SR 48692, and two enantiomeric analogs, SR 48527 and SR 49711, on neurotensin binding and contractile responses in guinea pig ileum and colon. J Pharmacol Exp Ther. 1994 Oct;271(1):267–276. [PubMed] [Google Scholar]
  16. Labbé-Jullié C., Dubuc I., Brouard A., Doulut S., Bourdel E., Pelaprat D., Mazella J., Martinez J., Rostène W., Costentin J. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes. J Pharmacol Exp Ther. 1994 Jan;268(1):328–336. [PubMed] [Google Scholar]
  17. Miller L. A., Cochrane D. E., Carraway R. E., Feldberg R. S. Blockade of mast cell histamine secretion in response to neurotensin by SR 48692, a nonpeptide antagonist of the neurotensin brain receptor. Br J Pharmacol. 1995 Apr;114(7):1466–1470. doi: 10.1111/j.1476-5381.1995.tb13371.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mulè F., Postorino A., Geraci A., Serio R. Neurotensin: dual effect on the motor activity of rat duodenum. Eur J Pharmacol. 1992 Mar 3;212(2-3):215–224. doi: 10.1016/0014-2999(92)90332-x. [DOI] [PubMed] [Google Scholar]
  19. Mulè F., Serio R., Postorino A. Motility pattern of isolated rat proximal colon and excitatory action of neurotensin. Eur J Pharmacol. 1995 Mar 6;275(2):131–137. doi: 10.1016/0014-2999(94)00760-5. [DOI] [PubMed] [Google Scholar]
  20. Prange A. J., Jr The manifold actions of neurotensin, a trophotropic agent. Ann N Y Acad Sci. 1992;668:298–306. doi: 10.1111/j.1749-6632.1992.tb27358.x. [DOI] [PubMed] [Google Scholar]
  21. Rostène W., Brouard A., Dana C., Masuo Y., Agid F., Vial M., Lhiaubet A. M., Pelaprat D. Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence. Ann N Y Acad Sci. 1992;668:217–231. doi: 10.1111/j.1749-6632.1992.tb27352.x. [DOI] [PubMed] [Google Scholar]
  22. Schultzberg M., Hökfelt T., Nilsson G., Terenius L., Rehfeld J. F., Brown M., Elde R., Goldstein M., Said S. Distribution of peptide- and catecholamine-containing neurons in the gastro-intestinal tract of rat and guinea-pig: immunohistochemical studies with antisera to substance P, vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin and dopamine beta-hydroxylase. Neuroscience. 1980;5(4):689–744. doi: 10.1016/0306-4522(80)90166-9. [DOI] [PubMed] [Google Scholar]
  23. Sundler F., Håkanson R., Hammer R. A., Alumets J., Carraway R., Leeman S. E., Zimmerman E. A. Immunohistochemical localization of neurotensin in endocrine cells of the gut. Cell Tissue Res. 1977 Mar 16;178(3):313–321. doi: 10.1007/BF00218696. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES